GTR 114055938
Tenders Are Invited For Pharmaceutical Products – Open House Biologics Discount Agreements 2026-24 - Aflibercept (Atc: S01la05; Potency: 40 Mg/Ml)
ICB — International Competitive Bid
Closes Jul 31, 2027
Western Europe
Tender Information
GTR Reference
114055938
Tendering Authority
Subscribe to view
Tender No
385850-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products – Open House Biologics Discount Agreements 2026-24 - Aflibercept (Atc: S01la05; Potency: 40 Mg/Ml)
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union,G20
Last Date of Bid Submission
31-07-2027
Work Detail
Pharmaceutical Products – Open House Biologics Discount Agreements 2026-24 - Aflibercept (Atc: S01la05; Potency: 40 Mg/Ml). The Tk Aims To Conclude Discount Agreements With All Suitable Pharmaceutical Companies In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Aflibercept (Atc: S01la05; Potency: 40 Mg/Ml).
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
0e6fcb8b-79cc-4b2f-8281-e924ec1e61f4.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.